Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities:: A novel series of potential antidepressants

被引:27
作者
Andrés, JI
Alcázar, J
Alonso, JM
Alvarez, RM
Cid, JM
De Lucas, AI
Fernández, J
Martínez, S
Nieto, C
Pastor, J
Bakker, MH
Biesmans, I
Heylen, LI
Megens, AA
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Dept Med Chem, Toledo 45007, Spain
[2] Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium
关键词
D O I
10.1016/S0960-894X(03)00525-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of a series of novel 3-piperazinyimethyl-3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles as novel dual 5-HT reuptake inhibitors and alpha(2)-adrenoceptor antagonists is described. Their affinity at the three different human alpha(2)-adrenoceptor subtypes and the 5-HT transporter site is reported. The in vivo activity of the compounds was measured in two different assays: (1) inhibition of pCA-induced excitation, which evaluates the ability to block the central 5-HT transporter, and (2) inhibition of xylazine-induced loss of righting, which evaluates the ability to block central alpha(2)-adrenoceptors. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2719 / 2725
页数:7
相关论文
共 28 条
[1]  
BARALDI PG, 1994, SYNTHESIS-STUTTGART, P1158
[2]   NEUROBIOLOGICAL MECHANISMS INVOLVED IN ANTIDEPRESSANT THERAPIES [J].
BRILEY, M ;
MORET, C .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) :387-400
[3]   YOHIMBINE AUGMENTATION OF FLUVOXAMINE IN REFRACTORY DEPRESSION - A SINGLE-BLIND STUDY [J].
CAPPIELLO, A ;
MCDOUGLE, CJ ;
MALISON, RT ;
HENINGER, GR ;
PRICE, LH .
BIOLOGICAL PSYCHIATRY, 1995, 38 (11) :765-767
[4]   Mirtazapine augmentation in the treatment of refractory depression [J].
Carpenter, LL ;
Jocic, Z ;
Hall, JM ;
Rasmussen, SA ;
Price, LH .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (01) :45-+
[5]   BIOCHEMISTRY OF AFFECTIVE DISORDERS [J].
COPPEN, A .
BRITISH JOURNAL OF PSYCHIATRY, 1967, 113 (504) :1237-+
[6]   Potential antidepressants displayed combined α2-adrenoceptor antagonist and monoamine uptake inhibitor properties [J].
Cordi, AA ;
Berque-Bestel, I ;
Persigand, T ;
Lacoste, JM ;
Newman-Tancredi, A ;
Audinot, V ;
Millan, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :787-805
[7]   PRESYNAPTIC ALPHA-RECEPTOR SUBSENSITIVITY AFTER LONG-TERM ANTIDEPRESSANT TREATMENT [J].
CREWS, FT ;
SMITH, CB .
SCIENCE, 1978, 202 (4365) :322-324
[8]  
CURRAN DP, 1988, ADV CYCLOADDITION, V1, P129
[9]   Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression [J].
Dam, J ;
Ryde, L ;
Svejso, J ;
Lauge, N ;
Lauritsen, B ;
Bech, P .
PHARMACOPSYCHIATRY, 1998, 31 (02) :48-54
[10]  
Dubini A, 1997, J PSYCHOPHARMACOL, V11, pS17